epirubicin has been researched along with Leukemia P388 in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 11 (73.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horton, D; Priebe, W; Varela, O | 2 |
| Cichocka, K; Górecki, P; Kuśnierczyk, H; Radzikowski, C | 1 |
| Di Simone, D; Grassi, B; Malvaldi, G; Mattii, L; Petrini, M; Testi, R; Zaccaro, L | 1 |
| Chitnis, M; Viladkar, A | 1 |
| Burke, TG; Perez-Soler, R; Priebe, W; Van, NT | 1 |
| Agata, N; Hirano, S; Iguchi, H; Izumi, H; Mase, T; Takeuchi, T; Tone, H | 1 |
| Furusawa, S; Hayashi, A; Sasaki, K; Takayanagi, M; Takayanagi, Y | 1 |
| Furusawa, S; Hayashi, A; Sasaki, K; Takasyanagi, Y; Takayanagi, M | 1 |
| Chiba, H; Furusawa, S; Nakano, S; Sasaki, K; Takayanagi, M; Takayanagi, Y; Wada, M | 1 |
| Alakhov, VY; Arjakov, SA; Batrakova, EV; Dorodnych, TY; Goncharova, ON; Kabanov, AV; Klinskii, EY; Kliushnenkova, EN; Shemchukova, OB | 1 |
| Chiba, H; Furusawa, S; Nakano, S; Sasaki, K; Takahashi, M; Takayanagi, M; Takayanagi, Y; Wu, J | 1 |
| Karaberis, E; Mourelatos, D | 1 |
| Kido, Y; Kobayashi, K; Matsuura, N; Mori, T; Murata, A; Nishijima, J; Ogawa, M; Shiozaki, H; Tsujinaka, T | 1 |
| Geran, R; Goldin, A; Venditti, JM | 1 |
1 review(s) available for epirubicin and Leukemia P388
| Article | Year |
|---|---|
The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.
Topics: Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Epirubicin; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Neoplasm Transplantation; Neoplasms, Experimental | 1985 |
14 other study(ies) available for epirubicin and Leukemia P388
| Article | Year |
|---|---|
Synthesis and antitumor activity of 3'-deamino-3'-hydroxydoxorubicin. A facile procedure for the preparation of doxorubicin analogs.
Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Epirubicin; Leukemia P388; Mice | 1984 |
3'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity.
Topics: Animals; Daunorubicin; Doxorubicin; Epirubicin; Leukemia P388; Mice; Structure-Activity Relationship | 1984 |
Comparative evaluation of toxicity and antitumor activity of original and reproduced anthracycline drugs.
Topics: Animals; Antibiotics, Antineoplastic; Chemistry, Pharmaceutical; Doxorubicin; Drug Screening Assays, Antitumor; Epirubicin; Female; Lethal Dose 50; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation | 1994 |
Evaluation of resistance index of several anticancer agents on parental and resistant P-388 cell lines.
Topics: Animals; Biological Transport; DNA Replication; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Idarubicin; In Vitro Techniques; Leukemia P388; Mice; Mitoxantrone; Tumor Cells, Cultured; Verapamil | 1995 |
Sensitization of P388 murine leukemia cells to epirubicin cytotoxicity by reserpine.
Topics: Animals; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Intracellular Fluid; Kinetics; Leukemia P388; Mice; Mice, Inbred Strains; Reserpine; Tumor Cells, Cultured | 1993 |
Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity.
Topics: Animals; Cardiolipins; Cell Survival; Doxorubicin; Drug Interactions; Drug Resistance; Epirubicin; Heart; Humans; KB Cells; Lethal Dose 50; Leukemia P388; Male; Mice; Mice, Inbred ICR; Tumor Cells, Cultured | 1993 |
Antitumor effects of pirarubicin and epirubicin in combination with doxifluridine and cisplatin against mouse P388 leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Epirubicin; Female; Floxuridine; Leukemia P388; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA | 1995 |
[Studies on reversing effect of multidrug resistance by dipyridamole. I. modulation of epirubicin-induced effects on cell proliferation and cell cycle by dipyridamole].
Topics: Animals; Antibiotics, Antineoplastic; Cell Cycle; Cell Division; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Epirubicin; Leukemia P388; Mice; Platelet Aggregation Inhibitors; Tumor Cells, Cultured | 1996 |
[Studies on reversing effect of multidrug resistance by dipyridamole. II. Inhibition of epirubicin efflux from resistant cells by dipyridamole and its pharmacological effect].
Topics: Animals; Antibiotics, Antineoplastic; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Epirubicin; Female; Leukemia P388; Male; Mice; Mice, Inbred Strains; Tumor Cells, Cultured | 1996 |
Augmentation of epirubicin cytotoxicity by cycloheximide.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cycloheximide; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Leukemia P388; Mice; Protein Synthesis Inhibitors; Tetrazolium Salts; Thiazoles | 1996 |
Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Female; Leukemia P388; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Micelles; Multiple Myeloma; Neoplasm Transplantation; Poloxalene | 1996 |
Reversal of multidrug resistance by tacrolimus hydrate.
Topics: Animals; Antibiotics, Antineoplastic; Cell Cycle; Cell Division; Cyclosporine; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Immunosuppressive Agents; L-Lactate Dehydrogenase; Leukemia P388; Mice; Tacrolimus; Tumor Cells, Cultured | 1996 |
Enhanced cytogenetic and antitumor effects by 9-nitrocamptothecin and antineoplastics.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Division; Drug Screening Assays, Antitumor; Epirubicin; Humans; Leukemia P388; Lymphocytes; Melphalan; Mice; Sister Chromatid Exchange | 2000 |
[A pilot study of the combination of 5-FU and epirubicin for gastric cancer as an adjuvant chemotherapy].
Topics: Administration, Oral; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Humans; Injections, Intravenous; Leukemia P388; Male; Mice; Middle Aged; Mitomycin; Mitomycins; Pilot Projects; Postoperative Care; Stomach Neoplasms | 1991 |